Omidubicel is an advanced NAM-enabled stem cell therapy candidate which is being developed as a potential life-saving allogeneic hematopoietic stem cell (bone marrow) transplant solution for blood cancer
The post US FDA grants priority review to Gamida Cell’s BLA for omidubicel appeared first on Pharmaceutical Business review.